Stay updated on Nivolumab and Ipilimumab Combination Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab Combination Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A related educational resource about melanoma is now listed among the study’s links.
    Difference
    0.1%
    Check dated 2026-11-14T13:58:08.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial record for nivolumab and ipilimumab in melanoma is now displayed, including study details, outcomes, and related documents, instead of a 403 Forbidden page.
    Difference
    84%
    Check dated 2026-11-07T13:46:24.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T14:49:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A sitewide NIH announcement says agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T16:49:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov error page displays an updated site revision label, changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:31:49.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1, while the study record remains inaccessible behind a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T16:50:15.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab Combination Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab Combination Clinical Trial page.